Literature DB >> 17357479

Different expressions of protein kinase C-alpha, beta I and beta II in glomeruli of diabetic nephropathy patients.

Lijun Yao1, Jianqing Wang, Yan Mao, Hongyan Zhu, Anguo Deng, Zhonghua Zhu.   

Abstract

In current study, the expressions of protein kinase C (PKC)-alpha, beta I and beta II as well as their correlation to the expression of transforming growth factor-beta I (TGF-beta I) and vascular endothelial growth factor (VEGF) were investigated in glomeruli of normal renal tissues taken from human kidney tumors and kidney tissues from patients with diabetic nephropathy (DN). The accumulation of glomerular extracellular matrix (ECM) was determined by PAS staining, the expressions of PKC-a, PKC-beta I, PKC-beta II, TGF-beta I and VEGF were measured by semi-quantitative immunohistochemistry. Our results showed that in glomeruli of normal renal tissues, PKC-alpha and beta II had a strong expression whereas the expression of PKC-beta I was weak; in glomeruli of DN patients, the expressions of PKC-alpha, PKC-beta I, VEGF and TGF-beta I and the accumulation of ECM increased significantly, but the expression of PKC-beta II decreased markedly. Meanwhile, the expressions of PKC-alpha and beta I had a positive correlation to the expressions of VEGF and TGF-beta I respectively, whereas PKC-beta II showed no correlation to VEGF and TGF-beta I. It is concluded that the expressions of PKC-alpha, beta I and beta II in glomeruli of normal subjects and DN patients are different. PKC-alpha seems to play a critical role in human DN by up-regulating VEGF expression, whereas PKC-beta I is relatively important for the up-regulation of TGF-beta I and the accumulation of ECM under diabetic conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17357479     DOI: 10.1007/s11596-006-0605-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Role of vascular endothelial growth factor in diabetic nephropathy.

Authors:  D R Cha; N H Kim; J W Yoon; S K Jo; W Y Cho; H K Kim; N H Won
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

Review 2.  Protein kinases C: potential targets for intervention in diabetic nephropathy.

Authors:  M Murphy; A McGinty; C Godson
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-09       Impact factor: 2.894

3.  Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats.

Authors:  N Kang; G Alexander; J K Park; C Maasch; I Buchwalow; F C Luft; H Haller
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

4.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Authors:  Duk-Hee Kang; Jeremy Hughes; Marilda Mazzali; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  Immunolocalization of protein kinase C isoenzymes alpha, beta1 and betaII in rat kidney.

Authors:  I L Pfaff; H J Wagner; V Vallon
Journal:  J Am Soc Nephrol       Date:  1999-09       Impact factor: 10.121

6.  Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.

Authors:  Jan Menne; Joon-Keun Park; Martin Boehne; Marlies Elger; Carsten Lindschau; Torsten Kirsch; Matthias Meier; Faikah Gueler; Annette Fiebeler; Ferdinand H Bahlmann; Michael Leitges; Hermann Haller
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

7.  Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.

Authors:  K Sharma; Y Jin; J Guo; F N Ziyadeh
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

8.  Immunolocalization of protein kinase C isoenzymes alpha, beta I, beta II, delta, and epsilon in mouse kidney.

Authors:  Stephanie Redling; Imke L Pfaff; Michael Leitges; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

9.  Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

Authors:  H Ishii; M R Jirousek; D Koya; C Takagi; P Xia; A Clermont; S E Bursell; T S Kern; L M Ballas; W F Heath; L E Stramm; E P Feener; G L King
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

  9 in total
  3 in total

1.  Different localization and expression of protein kinase C-beta in kidney cortex of diabetic nephropathy mice and its role in telmisartan treatment.

Authors:  Jianqing Wang; Fu Qin; Anguo Deng; Lijun Yao
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Amelioration of Hyperglycemia-Induced Nephropathy by 3,3'-Diindolylmethane in Diabetic Mice.

Authors:  Kyeong-Mi Choi; Hwan-Soo Yoo
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

Review 3.  The role of novel biomarkers in predicting diabetic nephropathy: a review.

Authors:  Samuel N Uwaezuoke
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.